| Fluorescence Cell-Based Screen to Confirm Inhibitors of Phorbol Myristate Acetate-Mediated P-Selectin Induction on Platelets - BioAssay Summary Assay Overview: Cell-based assay for inhibition of PMA (phorbol myristate acetate)-induced P-selectin surface expression. Washed platelets obtained from individual donors were treated with compounds found to show less than 50% inhibition in an SFLLRN-induced FITC phalloidin assay. Platelet samples were treated with 30 uM compound. Following compound addition, platelets were stimulated with 5 more .. |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compounds: Depositor Specified Assays Description: Keywords: Platelet, activation, P-selectin, PMA, Protein kinase C Assay Overview: Cell-based assay for inhibition of PMA (phorbol myristate acetate)-induced P-selectin surface expression. Washed platelets obtained from individual donors were treated with compounds found to show less than 50% inhibition in an SFLLRN-induced FITC phalloidin assay. Platelet samples were treated with 30 uM compound. Following compound addition, platelets were stimulated with 5 nM PMA. After a 15-minute incubation, phycoerythrin-labeled anti-P-selectin antibody (BD Biosciences) was added for a 20-minute incubation. The samples were analyzed by flow cytometry to determine P-selectin expression on the surface of the platelets as a response to activation. Geometric mean values were collected for each sample. Expected Outcome: This assay serves as a specificity assay, along with an analogous assay using Ca2+-ionophore-induced activation of platelets, to determine selectivity towards G-protein coupled receptors (GPCR). Compounds that do not inhibit surface expression of P-selectin from PMA-induced and Ca2+-ionophore-induced activation are potential GPCR-selective inhibitors. Primary Collaborators(and laboratory where this assay was performed): Robert Flaumenhaft, Beth Israel Deaconess Medical Center,rflaumen@bidmc.harvard.edu,617-754-1204 John Thomas,NHLBI,ThomasJ@nhlbi.nih.gov Protocol 1. Platelet samples (10 ul) were incubated with 30 uM compound. 2. 20 minutes following compound addition, platelets were stimulated with 5 nM PMA. 3. After a 15-minute incubation, phycoerythrin-labeled anti-P-selectin antibody (5 ul; BD Biosciences) was added. The samples were agitated gently. 4. After a 20-minute incubation, 500 ul of FACS buffer (BD Biosciences) was added to each of the samples. 5. Samples were then analyzed by flow cytometry to determine P-selectin expression on the surface of the platelets as a response to activation. 6. Geometric mean values were collected for each sample. Comment Data analysis: The neutral control was: DMSO only, with no compound. Compounds were tested at 30uM. Percent inhibition of induced P-Selectin expression was calculated as: 100 - (100 * (Mean Fluorescence at 30uM/ Mean Fluorescence at DMSO)) The percent inhibition is reported for two replicates in each run. PUBCHEM_ACTIVITY_SCORE The average Percent Inhibition value at the tested concentration 30uM, calculated across all runs. PUBCHEM_ACTIVITY_OUTCOME Activity_Outcome = 1 (inactive) score <= 50 in all runs Activity_Outcome = 2 (active) score > 50 in all runs Activity_Outcome = 3 (inconclusive) score > 50 in one or more runs and score <= 50 in one or more runs Compounds were retested at least once. These retests were analyzed as independent tests; therefore each test generated a separate set of replicate data, including a score (average percent inhibition across replicates) and an outcome (2 (active) for score > 50). Result Definitions
Additional Information Grant Number: 1R03DA026209-01 Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||